Yn ddiweddar, cyhoeddais ddatganiad yn eich hysbysu bod yr Asiantaeth Rheoleiddio Meddyginiaethau a Chynhyrchion Gofal Iechyd (MHRA) wedi cymeradwyo’r brechlyn deufalent Moderna mRNA. Rwy’n falch o gyhoeddi bod yr MHRA bellach wedi cymeradwyo’r brechlyn deufalent Pfizer mRNA. Yn sgil hynny, mae'r JCVI wedi argymell y gellir defnyddio’r brechlyn deufalent hwn fel dos atgyfnerthu unigol yn ymgyrch yr hydref.
I recently issued a statement informing you that the Medicines and Healthcare products Regulatory Agency (MHRA) had granted approval of the Moderna mRNA bivalent vaccine. I am pleased to announce that the MHRA have now granted approval of the Pfizer mRNA bivalent vaccine. The JCVI has subsequently recommended this bivalent vaccine for use as a single booster dose in the autumn campaign.